Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood samples. With the new service, Quest Diagnostics now provides healthcare providers in the United States access to COVID-19 antibody as well as molecular diagnostic laboratory testing.
Testing and early detection is the clinical mission. The Pinnacle BioLabs COVID-19 Novel Coronavirus Dual IgG/IgM Rapid Test is empowering physicians by providing a 15 minute assay utilizing one drop of whole blood.
CareSaver Network is proud to offer its customers special access to Pinnacle BioLabs COVID-19 test kits as part of its on-site COVID-19 Testing-Training-Tracking[...]